Analytical Data
-
基因名
DYSFIP1
- Application
-
别名
PPP1R27; DYSFIP1; Protein phosphatase 1 regulatory subunit 27; Dysferlin-interacting protein 1; Toonin
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q86WC6
-
表达区间
1-154aa
-
氨基酸序列
MPSRTARYARYSPRQRRRRMLADRSVRFPNDVLFLDHIRQGDLEQVGRFIRTRKVSLATIHPSGLAALHEAVLSGNLECVKLLVKYGADIHQRDEAGWTPLHIACSDGYPDIARYLISLGADRDATNDDGDLPSDLIDPDYKELVELFKGTTMD
-
分子量
43.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DYSFIP1, a recently identified protein, is gaining attention due to its potential involvement in various cellular processes, including immune response and inflammation. Studies indicate that DYSFIP1 may play a role in the regulation of cytokine production and the modulation of immune cell function, suggesting its significant impact on maintaining immune homeostasis. Research into DYSFIP1 recombinant protein has been prompted by its implications in diseases where the immune system is compromised or dysregulated, such as autoimmune disorders and chronic inflammatory conditions. Understanding the structure and function of DYSFIP1 through recombinant expression could provide insights into its mechanisms of action and facilitate the development of therapeutic strategies aimed at modulating immune responses. Furthermore, the characterization of this protein may reveal novel biomarkers for disease diagnosis and prognosis, highlighting the importance of investigating DYSFIP1 in the context of both basic research and clinical applications. Overall, the study of DYSFIP1 recombinant protein is an emerging field with the potential to contribute significantly to our comprehension of immune regulation and its implications for health and disease.
